Study summary · research use only
[Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review summarizes long-term studies on the clinical efficacy of peptide bioregulators (Timalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin) for the prevention of diseases and treatment of human patients of different ages. Special attention is given by the authors to analysis of the use of peptide bioregulators as geroprotectors.
Abstract
The review summarizes the results of long-term studies of the authors on the clinical efficacy of peptide bioregulators (Timalin, Thymogen, Vilon, Epithalamin, Prostatilen, Cortexin, Retinalamin) for the prevention of diseases and treatment of people of different age. Special attention is given to the analysis of the use of peptide bioregulators as geroprotectors.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.